학술논문

Determinants of Urogenital Schistosomiasis Among Pregnant Women and its Association With Pregnancy Outcomes, Neonatal Deaths, and Child Growth.
Document Type
Journal Article
Source
Journal of Infectious Diseases. 4/15/2021, Vol. 223 Issue 8, p1433-1444. 12p.
Subject
*PREGNANCY outcomes
*PREGNANT women
*NEONATAL death
*GROWTH of children
*SCHISTOSOMIASIS
*RESEARCH
*TREMATODA
*CHILD development
*ANIMAL experimentation
*MICROSCOPY
*RESEARCH methodology
*EVALUATION research
*PERINATAL death
*COMPARATIVE studies
*BIRTH weight
*RESEARCH funding
*HEMATURIA
*URINALYSIS
*PARASITIC diseases in pregnancy
*DISEASE complications
Language
ISSN
0022-1899
Abstract
Background: Schistosoma haematobium is a parasitic helminth that causes urogenital pathology. The impact of urogenital schistosomiasis during pregnancy on birth outcomes and child growth is poorly understood.Methods: Risk factors for urogenital schistosomiasis were characterized among 4437 pregnant women enrolled in a cluster-randomized community-based trial in rural Zimbabwe. Infection was defined via urine microscopy (≥1 S. haematobium egg) and urinalysis (hematuria). Associations between infection and pregnancy outcomes were assessed in case-control analyses using conditional logistic regression. The association of maternal infection with birthweight and length-for-age Z scores (LAZ) at 1 and 18 months of age were assessed using generalized estimating equations.Results: Urogenital schistosomiasis (egg positive and/or hematuria positive) was detected in 26.8% of pregnant women. Risk factors significantly associated with infection were maternal age, education, marital status, and religion; household drinking water source and latrine; study region; and season. Urogenital schistosomiasis was not significantly associated with adverse pregnancy outcomes (miscarriage, stillbirth, preterm, and small-for-gestational age), birthweight, neonatal death, or LAZ.Conclusions: Including pregnant women in antihelminthic treatment programs would benefit a large number of women in rural Zimbabwe. However, clearance of the low-intensity infections that predominate in this context is unlikely to have additive benefits for pregnancy outcomes or child growth.Clinical Trials Registration: NCT01824940. [ABSTRACT FROM AUTHOR]